PATENT CLAIM ANALYSIS

Application Number: 16182720
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "411000"]

Abstract:
Small molecule carbazole compounds for use as androgen receptor inhibitors are provided herein. Also provided herein are methods for using the carbazole compounds in treating prostate cancer, including castration-resistant prostate cancer and enzalutamide-resistant prostate cancer. The methods include administering to a subject an effective amount of a compound or composition as described herein.

Claim (Index 2):
The compound of  claim 1 , wherein the compound is

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.39024
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15749383', '15346743', '15222734', '15331777', '15135334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780030435990919
- 35 USC 102 Novelty (BERT): 0.6829684060759641
- Combined Prediction Score: 0.7703242329994235
- Mean Citation Score: 459.834436
- Max Citation Score: 712.17395
- Similarity Product: 653.2535102595598

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test